Hey mate, curious about your view for Canada - do you know if the Canadian revenues fall under the bracket that qualify for the milestone? I can’t remember. It’s possible that Acadia have sales milestones for North America hence Canadian sales will fall under it.
But I don’t think pricing will be that attractive in any region other than the USA. As we know the USA prices drugs in a crazy way.
Only once launched and approved across majority of the globe do I believe there will be a cumulative effect of the revenues on the share price.
Share Price, page-11029
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.77 |
Change
-0.040(0.29%) |
Mkt cap ! $1.765B | |||
| Open | High | Low | Value | Volume |
| $13.82 | $13.91 | $13.72 | $571.5K | 41.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 171 | $13.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 570 | 12 |
View Market Depth
| Last trade - 10.43am 11/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |